Table 1 Patient characteristics at baseline and randomization
|  | Total RDT positives screened [n = 181] | Randomized to primaquine [n = 70] | Not randomized to primaquine [n = 70] |
|---|---|---|---|
Age (years) | 32.1 (24.8–38.7) | 32.2 (24.8–39.6) | 32.4 (24.3–38.8) |
Gender, female n (%) | 55 (30.4) | 22 (31.4) | 16 (22.9) |
Bodyweight (kg) | 60 (55–64) | 60 (53–63) | 60 (55–64) |
Day 0 haemoglobin (g/dL) | 12.9 (11.3–14.2) | 13.0 (11.6–14.5) | 13.3 (11.6–14.5) |
Day 0 anaemia (< 10 g/dL) | 14/177 (7.9) | 4/70 (5.7) | 3/69 (4.4) |
Day 3 haemoglobin (g/dL) | 12.5 (11.2–13.7) | 12.4 (11.3–13.9) | 13.0 (11.7–13.6) |
Day 3 anaemia (< 10 g/dL) | 18/150 (12.0) | 5/70 (7.1) | 7/70 (10) |
Day 0 asexual parasite density/per µL, geometric mean (95% CI) | 5554 (3971–7768) | 5048 (2933–8688) | 4769 (2782–8175) |
Day 0 multiplicity of infection (2 or more clones detected) | 121/165 (73.3) | 41/65 (63.1) | 50/63 (79.4) |
Day 0 gametocyte prevalence by microscopy | 5 (2.3) | 3 (4.3) | 2 (2.9) |
Day 0 gametocyte prevalence by PCR | 109/176 (61.9) | 48/69 (57.8) | 35/68 (42.2) |